This inventor holds 3 USPTO granted patents. Top assignee: Onyx Pharmaceuticals, Inc.. Active years: 2006-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2009
Title: Amy M Delaney: Innovator in Cytosine Deaminase Research
Introduction
Amy M Delaney is a prominent inventor based in Belleville, MI (US). She has made significant contributions to the field of biotechnology, particularly in the development of cytosine deaminase genes and proteins. With a total of three patents to her name, her work has the potential to impact cancer treatment and drug development.
Latest Patents
Among her latest patents, Amy has developed a new cytosine deaminase gene and protein that demonstrates an increased ability to convert the 5-fluorocytosine prodrug into its toxic form. This advancement is notable when compared to existing enzymes, showcasing her innovative approach to enhancing therapeutic efficacy.
Career Highlights
Amy M Delaney is currently employed at Onyx Pharmaceuticals, Inc., where she continues to push the boundaries of research in her field. Her work is characterized by a commitment to improving drug conversion processes, which is crucial for the development of effective cancer therapies.
Collaborations
Throughout her career, Amy has collaborated with esteemed colleagues such as Yuqiao Shen and Sylvie Laquerre. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Amy M Delaney is a trailblazer in the field of biotechnology, with her innovative patents and collaborative spirit driving advancements in cancer treatment. Her contributions are paving the way for future developments in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile